These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 18023953)

  • 21. Prices, availability and affordability of medicines in Rwanda.
    Bizimana T; Kayumba PC; Heide L
    PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Access to essential medicines for sexual and reproductive health care: the role of the pharmaceutical industry and international regulation.
    Cottingham J; Berer M
    Reprod Health Matters; 2011 Nov; 19(38):69-84. PubMed ID: 22118143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Globalization, global health, and access to healthcare.
    Collins T
    Int J Health Plann Manage; 2003; 18(2):97-104. PubMed ID: 12841150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical policy of the Andean sub-region.
    Essent Drugs Monit; 1993; (16):13-5. PubMed ID: 12319050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parents' and guardians' perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa - a qualitative study.
    Perumal-Pillay VA; Suleman F
    BMC Health Serv Res; 2017 Jun; 17(1):417. PubMed ID: 28629443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Access as a policy-relevant concept in low- and middle-income countries.
    McIntyre D; Thiede M; Birch S
    Health Econ Policy Law; 2009 Apr; 4(Pt 2):179-93. PubMed ID: 19187569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Access to inhaled corticosteroids is key to improving quality of care for asthma in developing countries.
    Ait-Khaled N; Enarson DA; Bissell K; Billo NE
    Allergy; 2007 Mar; 62(3):230-6. PubMed ID: 17298339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global aspects of drug development.
    Hoppu K; Hogerzeil HV
    Handb Exp Pharmacol; 2011; 205():353-72. PubMed ID: 21882121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When medicine becomes a disease.
    Arabia; 1986 Mar; 5(55):32-6. PubMed ID: 12340711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Price, availability and affordability of medicines.
    Mhlanga BS; Suleman F
    Afr J Prim Health Care Fam Med; 2014 Jun; 6(1):E1-6. PubMed ID: 26245401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of privatization of the drug distribution system on drug prices in Malaysia.
    Babar ZD; Izham MI
    Public Health; 2009 Aug; 123(8):523-33. PubMed ID: 19665741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Access to essential medicines for children: the world health organization's global response.
    Zucker H; Rägo L
    Clin Pharmacol Ther; 2007 Nov; 82(5):503-5. PubMed ID: 17952106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
    Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
    PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [International reference prices and cost minimization analysis for the regulation of medicine prices in Colombia].
    Vacca C; Acosta A; Rodriguez I
    Value Health; 2011; 14(5 Suppl 1):S16-9. PubMed ID: 21839891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Access for all to quality drugs].
    Videau JY
    Med Trop (Mars); 2002; 62(4):396-400. PubMed ID: 12534178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary: will generic drug stores improve access to essential medicines for the poor in India?
    Kotwani A
    J Public Health Policy; 2010 Jul; 31(2):178-84. PubMed ID: 20535100
    [No Abstract]   [Full Text] [Related]  

  • 38. The morally uncomfortable global drug gap.
    Cohen-Kohler JC
    Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings.
    Russo G; McPake B
    Health Policy Plan; 2010 Jan; 25(1):70-84. PubMed ID: 19843636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal.
    Khanal S; Veerman L; Ewen M; Nissen L; Hollingworth S
    Inquiry; 2019; 56():46958019887572. PubMed ID: 31823665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.